Abstract
Primary CNS lymphoma (PCNSL) is a rare and aggressive brain tumour that is uniformly fatal. The rarity of the disease and the poor response to treatment makes it difficult to reach a consensus with regards to treatment options. In this review, the authors have discussed different treatment modalities used in the management of PCNSL including chemotherapy, surgery and radiation, as well as the results of recent clinical trials on treatment options for PCNSL.
Original language | English |
---|---|
Pages (from-to) | 497-498 |
Number of pages | 2 |
Journal | Journal of the Pakistan Medical Association |
Volume | 68 |
Issue number | 3 |
Publication status | Published - Mar 2018 |
Keywords
- Cerebral malignancy
- Chemotherapy
- Primary CNS Lymphoma
- Radiotherapy